Assignee
ESSENTIALIS INC
US16 patents
Top patents by PatentIndex Score
US7572789B2Aug 11, 2009
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC74 citations96
US10058557B2Aug 28, 2018
Methods for treating subjects with prader-willi syndrome or smith-magenis syndrome
ESSENTIALIS INC12 citations92
US10085998B2Oct 2, 2018
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC12 citations91
US9381202B2Jul 5, 2016
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC12 citations91
US7799777B2Sep 21, 2010
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC14 citations91
US12178823B1Dec 31, 2024
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC3 citations85
US12109216B2Oct 8, 2024
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC3 citations85
US11786536B2Oct 17, 2023
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC4 citations84
US11045478B2Jun 29, 2021
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC5 citations83
US10874676B2Dec 29, 2020
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC6 citations83
US10456408B2Oct 29, 2019
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC7 citations83
US9757384B2Sep 12, 2017
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC10 citations83
US9765043B2Sep 19, 2017
Salts of potassium ATP channel openers and uses thereof
ESSENTIALIS INC10 citations76
US12343348B2Jul 1, 2025
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
ESSENTIALIS INC2 citations74
US9782416B2Oct 10, 2017
Pharmaceutical formulations of potassium ATP channel openers and uses thereof
ESSENTIALIS INC12 citations70
US12419895B1Sep 23, 2025
Methods for treating subjects with Prader-Willi syndrome
ESSENTIALIS INC0 citations62